Allina launches COVID-19 vaccine trial in Minnesota
November 6, 2020
A second COVID-19 vaccine trial is launching in Minnesota as infections, hospitalizations and deaths rise in the pandemic.
Allina Health on Monday enrolled its first 10 participants, who either received an experimental vaccine made by Janssen Pharmaceuticals Inc. or a nonmedicating placebo at the trial site in Minneapolis.
The goal is to enroll hundreds of local participants this winter to learn how the vaccine works and compares with others being rapidly developed against the highly infectious SARS-CoV-2 virus that causes COVID-19, said Dr. Frank Rhame, the Allina virologist running the Ensemble trial.